Myth: “You might Only Get a Sugar Pill?” The truth about placebos and follicular lymphoma trials
Our second myth busting article of the series, where we breakdown the common myths around clinical trials and placebo’s and share about clinical trial work supported the FLF.
Busting the myth: clinical trials are not just about treatment
Our first myth busting article of the series, where we breakdown the common myths around clinical trials and treatment and share about clinical trial work supported the FLF.
Science Simplified: Biomarkers in Follicular Lymphoma – can we better predict outcomes?
In this “Science Simplified” series, we’ll be sharing insights from the latest research presented at the American Society of Hematology (ASH) conference in December 2025.
Science Simplified: What’s new in treating relapse in FL? Part 2: Targeted Treatment
In this “Science Simplified” series, we’ll be sharing insights from the latest research presented at the American Society of Hematology (ASH) conference in December 2025.
Science Simplified: What’s new in treating relapse in FL? Part 1: T-cell engaging immunotherapy
In this “Science Simplified” series, we’ll be sharing insights from the latest research presented at the American Society of Hematology (ASH) conference in December 2025.
Science Simplified – What Treatment Should I Start With?
What is the best first treatment for follicular lymphoma? We break down current standards, new research from ASH 2025, and what it could mean for your care.
Science simplified- Who needs treatment and when?
In this “Science Simplified” series, we’ll be sharing insights from the latest research presented at the American Society of Hematology (ASH) conference in December 2025.
Science simplified- how to make sense of research
In our upcoming “Science Simplified” series, we’ll be sharing insights from the latest research presented to us at the American Society of Hematology(ASH) conference . But before we explore that in detail, it is important to explain how we, and you, can read research critically.
Finding a Clinical Trial: Dr. Mitchell Smith, FLF Chief Medical Officer, Provides Expert Advice on Your Important Questions
In this Q&A, Dr. Mitchell Smith dives into common questions on how to find and join a clinical trial, helping you navigate the complexities for follicular lymphoma patients.
Transformation vs Progression: What Patients Need To Know
Understanding the difference can help you feel more in control, ask the right questions at appointments, and better navigate what may come next.